Executive Director, Strategy & Commercial Development, Neuroscience

About the role

The Executive Director, Neurodegeneration Strategy and Commercial Development will serve as the commercial leader accountable for maximizing the value of BMS's rapidly expanding neurodegeneration portfolio, spanning Alzheimer's disease, Parkinson's disease/Dementia with Lewy Bodies (DLB), and other neurodegenerative conditions. This role defines and executes integrated strategy, manages a diverse pipeline of early‑ and mid‑stage assets, and owns Market Development to build BMS’s presence in these new areas. The leader provides commercial leadership from Discovery through Phase 3, partners with Development, Medical, Regulatory, CMC, Commercial, and Project Leadership, and works closely with Business Insights & Analytics and Value, Access & Pricing to ensure commercial input into product development decisions. Domestic and international travel of approximately 20 % is required.

Key Responsibilities

• Leads worldwide brand planning and long‑range forecasting across the neurodegeneration pipeline, including assets from Discovery through Phase 2b/3 in Alzheimer’s, Parkinson’s, and other neurodegenerative conditions.
• Owns Neurodegeneration Market Development, including biomarker and diagnosis strategy, patient identification pathways, and preparation of markets for launch.
• Sets the strategic direction for neurodegeneration and ensures alignment of day‑to‑day execution with overall franchise strategy.
• Ensures comprehensive assessment of competitive data and emerging trends, integrating implications into brand strategy and plans in rapidly evolving spaces.
• Translates new clinical and scientific evidence into brand strategy to maximize appropriate patient usage.
• Partners with opinion leaders, advocacy groups, external agencies, and other stakeholders to reinforce BMS's commitment to neurodegeneration and build BMS's presence.
• Collaborates with the worldwide Value, Access, and Pricing team to optimize access and uptake at launch through development strategies that meet future market needs.
• Builds a deep understanding of local market dynamics, including customer and competitive insights, and identifies growth opportunities to drive global development and launch.
• Leads and influences cross‑functional teams to guide optimized development for future commercial success.
• Develops the strategic and long‑range plan for neurodegeneration and guides products through successful transition at key stage gates, representing key products to Executive Management.
• Demonstrates the ability to develop strategies and build relationships with stakeholders to establish BMS's presence in new neurodegeneration therapeutic areas.

Qualifications & Experience

• BA/BS required; life sciences degree or equivalent desirable. MBA or graduate degree highly preferred.
• At least 12 years of progressive industry experience with a proven track record of success across products in various stages of development, from pipeline to launch to in‑market.
• US and global experience preferred.
• Functional experience within Alzheimer's disease and/or movement disorders (Parkinson's/DLB) preferred.
• Demonstrated scientific acumen and understanding of drug development processes, regulatory pathways, product design, and new product evaluation.
• Understanding of commercial aspects of drug development, including global/country market dynamics, operational feasibility, market access, patient advocacy, and regulatory/reimbursement challenges.
• People‑leadership experience, including managing and developing direct reports.
• Strong collaboration skills to incorporate internal and external stakeholder needs into commercial planning.
• Critical assessment ability with disciplined thinking to determine what is best for patients and the business, and to influence and build alignment with stakeholders.
• Strong financial acumen, capable of assimilating complex information to create and manage budgets and meet financial targets.
• Proven breadth and depth of experience across marketing competencies with exemplary achievement of performance objectives.
• Experience leading strategically, communicating with impact, and creating an inclusive, energizing culture consistent with BMS values.
• Ability to mobilize matrix team members and embrace teamwork within a cross‑functional environment.
• Knowledge of AI resources and how to utilize them to enhance productivity and quality outputs.

Why You Should Apply

At Bristol Myers Squibb, we are passionate about making an impact on the lives of patients with serious disease. Our inclusive culture, shared values of passion, innovation, urgency, accountability, inclusion, and integrity empower colleagues to reach their highest potential. We offer a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits, providing resources to pursue both professional and personal goals.

Compensation

Salary range: $239,080 – $289,708 for full‑time employees. Additional discretionary incentive cash and stock opportunities may be available. Pay is determined based on role, skills, location, schedule, and experience, guided by pay equity principles and applicable laws.

Benefits

• Comprehensive benefit plans including wellbeing support, retirement and financial protection, and medical, dental, vision, life, and disability insurance.
• Flexible Time Off (FTO) for U.S. exempt employees—paid time off without a set accrual limit, subject to manager approval.
• 11 paid company holidays each year.
• For non‑exempt, RayzeBio, and Puerto Rico employees: 160 hours of paid vacation annually for new hires, plus 11 paid holidays and 3 optional holidays.
• Additional time‑off benefits such as paid sick leave, up to two paid volunteer days per year, summer hours flexibility, and various leaves of absence (medical, personal, parental, caregiver, bereavement, military).
• Annual Global Shutdown between Christmas Day and New Year’s Day.